科研成果详情

题名A novel adipocytokine visfatin protects against H2O2-induced myocardial apoptosis: A missing link between obesity and cardiovascular disease
作者
发表日期2013-03
发表期刊JOURNAL OF CELLULAR PHYSIOLOGY   影响因子和分区
语种英语
原始文献类型Article
其他关键词COLONY-ENHANCING FACTOR ; METABOLIC SYNDROME ; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE ; EXPRESSION ; IMPACT ; CARDIOMYOCYTES ; OUTCOMES ; THERAPY ; PARADOX ; PATHWAY
摘要Fat accumulation in obese individuals worsens the clinical outcomes of cardiovascular disease (CVD). Paradoxically, increased circulating adipocytokines secreted from visceral fat may confer cardioprotective effects. Visfatin, a novel adipocytokine, has anti-diabetic, anti-tumor, and pro-inflammatory properties. However, its effects on cardiomyocytes and the underlying mechanisms remain unknown. This article demonstrated that visfatin counteracted H2O2-induced apoptotic damage in H9c2 cardiomyocytes in a time-dependent manner. Qualitative immunofluorescence approaches demonstrated that visfatin pretreatment attenuated H2O2-induced DNA fragmentation (TdT-mediated dUTP-biotin nick end-labeling), phosphatidyl serine exposure (Annexin V/PI staining), and mitochondrial membrane potential (??m) depolarization (JC-1 staining). Biochemical studies on cardiomyoctes showed improved cell viability and reduced caspase-3 activation caused by visfatin pretreatment. Visfatin did not inhibit the death receptor-dependent apoptotic pathways, as characterized by its absence in both Fas and TNFR1 down-regulation. Instead, visfatin specifically suppressed the mitochondria-dependent apoptotic pathways, as characterized by changed levels of p53 and its downstream Bcl-2 family genes. Visfatin also up-regulated the protein levels of phosphorylated AMPK, and the anti-apoptotic action of visfatin was attenuated by the AMPK-specific inhibitor compound C. These results suggested that visfatin plays a critical role in cardioprotection by suppressing myocardial apoptosis via AMPK activation. These findings may be the missing link between obesity and CVD. J. Cell. Physiol. 228: 495501, 2013. (C) 2012 Wiley Periodicals, Inc.
资助项目Major scientific and technological special project for significant new drugs formulation [2012ZX09501001]; Chinese Postdoctoral Science FoundationChina Postdoctoral Science Foundation [20110490325]
出版者WILEY
出版地HOBOKEN
ISSN0021-9541
EISSN1097-4652
卷号228期号:3页码:495-501
DOI10.1002/jcp.24257
页数7
WOS类目Cell Biology ; Physiology
WOS研究方向Cell Biology ; Physiology
WOS记录号WOS:000311912900001
收录类别SCIE ; SCOPUS
URL查看原文
PubMed ID23065734
SCOPUSEID2-s2.0-84870398212
通讯作者地址[Sun, Xiao-Bo]Chinese Acad Med Sci, Inst Med Plant Dev IMPLAD, Res Ctr Pharmacol & Toxicol, 151 Malianwa N Rd, Beijing 100193, Peoples R China.
引用统计
被引频次:27[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/8560
专题第二临床医学院、附属第二医院、育英儿童医院_中医系
通讯作者Sun, Xiao-Bo
作者单位
1.Chinese Acad Med Sci, Inst Med Plant Dev IMPLAD, Res Ctr Pharmacol & Toxicol, Beijing 100193, Peoples R China;
2.Peking Union Med Coll, Beijing 100193, Peoples R China;
3.Wenzhou Med Coll, Acad Chinese Mat Med, Wenzhou, Peoples R China
推荐引用方式
GB/T 7714
Xiao, Jing,Sun, Bing,Li, Ming,et al. A novel adipocytokine visfatin protects against H2O2-induced myocardial apoptosis: A missing link between obesity and cardiovascular disease[J]. JOURNAL OF CELLULAR PHYSIOLOGY,2013,228(3):495-501.
APA Xiao, Jing, Sun, Bing, Li, Ming, Wu, Ying, & Sun, Xiao-Bo. (2013). A novel adipocytokine visfatin protects against H2O2-induced myocardial apoptosis: A missing link between obesity and cardiovascular disease. JOURNAL OF CELLULAR PHYSIOLOGY, 228(3), 495-501.
MLA Xiao, Jing,et al."A novel adipocytokine visfatin protects against H2O2-induced myocardial apoptosis: A missing link between obesity and cardiovascular disease".JOURNAL OF CELLULAR PHYSIOLOGY 228.3(2013):495-501.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Xiao, Jing]的文章
[Sun, Bing]的文章
[Li, Ming]的文章
百度学术
百度学术中相似的文章
[Xiao, Jing]的文章
[Sun, Bing]的文章
[Li, Ming]的文章
必应学术
必应学术中相似的文章
[Xiao, Jing]的文章
[Sun, Bing]的文章
[Li, Ming]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。